CARA
Cara Therapeutics Inc
Price:  
0.25 
USD
Volume:  
356,241.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA EV/EBITDA

-12556.7%
Upside

As of 2024-10-12, the EV/EBITDA ratio of Cara Therapeutics Inc (CARA) is 0.33. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CARA's latest enterprise value is -35.49 mil USD. CARA's TTM EBITDA according to its financial statements is -107.73 mil USD. Dividing these 2 quantities gives us the above CARA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.2x - 13.2x 12.6x
Forward P/E multiples 17.3x - 21.2x 20.0x
Fair Price (33.16) - (24.99) (31.22)
Upside -13332.7% - -10072.1% -12556.7%
0.25 USD
Stock Price
(31.22) USD
Fair Price

CARA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-11 0.33
2024-10-10 0.33
2024-10-09 0.32
2024-10-08 0.33
2024-10-07 0.32
2024-10-04 0.32
2024-10-03 0.32
2024-10-02 0.31
2024-10-01 0.31
2024-09-30 0.30
2024-09-27 0.30
2024-09-26 0.31
2024-09-25 0.32
2024-09-24 0.31
2024-09-23 0.30
2024-09-20 0.30
2024-09-19 0.30
2024-09-18 0.31
2024-09-17 0.32
2024-09-16 0.32
2024-09-13 0.32
2024-09-12 0.32
2024-09-11 0.31
2024-09-10 0.31
2024-09-09 0.30
2024-09-06 0.29
2024-09-05 0.29
2024-09-04 0.29
2024-09-03 0.29
2024-08-30 0.27
2024-08-29 0.28
2024-08-28 0.28
2024-08-27 0.27
2024-08-26 0.27
2024-08-23 0.28
2024-08-22 0.28
2024-08-21 0.28
2024-08-20 0.28
2024-08-19 0.29
2024-08-16 0.29
2024-08-15 0.29
2024-08-14 0.29
2024-08-13 0.28
2024-08-12 0.29
2024-08-09 0.28
2024-08-08 0.28
2024-08-07 0.28
2024-08-06 0.27
2024-08-05 0.28
2024-08-02 0.28